Denali Therapeutics Inc Earnings logo

DNLI

Denali Therapeutics Inc Earnings

$21.45

Earnings Summary

Net Profits
$-107.19Mn
Highlights
Net Profits:

Denali Therapeutics Inc’s net profit fell -7.89% since last year same period to $-107.19Mn in the Q3 2024. On a quarterly growth basis, Denali Therapeutics Inc has generated -8.25% fall in its net profits since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Denali Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter
-0.61
EPS Estimate Current Year
-0.61
Highlights
EPS Estimate Current Quarter:

Denali Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.61 - a 11.59% jump from last quarter’s estimates.

EPS Estimate Current Year:

Denali Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.61.

Key Ratios

Key ratios of the Denali Therapeutics Inc post its Q3 2024 earnings
Earning Per Share (EPS)
-0.63
Highlights
Earning Per Share (EPS):

Denali Therapeutics Inc’s earning per share (EPS) jumped 12.5% since last year same period to -0.63 in the Q3 2024. This indicates that the Denali Therapeutics Inc has generated 12.5% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-11-06
-0.61
-0.63
-3.28%
2024-05-07
-0.7
-0.78
-11.43%
2024-08-01
-0.69
-0.59
14.49%